Palvella Therapeutics (PVLA) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -7.63% |
| Mar 31, 2023 | -6.36% |
| Dec 31, 2022 | -4.49% |
| Sep 30, 2022 | 13.03% |
| Jun 30, 2022 | 30.25% |
| Mar 31, 2022 | 56.76% |
| Dec 31, 2021 | 55.87% |
| Sep 30, 2021 | 61.14% |
| Jun 30, 2021 | 64.26% |
| Mar 31, 2021 | 66.49% |
| Dec 31, 2020 | 76.14% |
| Sep 30, 2020 | 83.63% |
| Jun 30, 2020 | 88.02% |
| Mar 31, 2020 | 89.43% |
| Dec 31, 2019 | 104.99% |
| Sep 30, 2019 | 65.06% |
| Jun 30, 2019 | 47.72% |
| Mar 31, 2019 | 30.33% |
| Dec 31, 2018 | 32.66% |
| Sep 30, 2018 | 34.46% |
| Jun 30, 2018 | 36.40% |
| Mar 31, 2018 | 35.52% |
| Dec 31, 2017 | 25.27% |
| Dec 31, 2016 | -2.43% |